Aligo Venture Capital
VC Fund
Tczew, Poland
Aligo Venture Capital is a VC fund in Tczew focused on Health Care and Medical Device. Aligo is a group of experts with extensive expertise in capital investments, research and development project funding, and the commercialization of innovative goods. Aligo's business is investing in early-stage companies (start-ups / early stage), which have already assembled a project team and secured their first clients.
- Total investments:
- 35
- Last investment:
- Lead investor:
- 46%
Last updated:
For AI agents: llms.txt
Industries Aligo Venture Capital invests in
Stages Aligo Venture Capital invests in
Countries Aligo Venture Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $241k–$682k
- Pre-Seed
- $250k–$702k
Investment Focus
Industry
- Health Care 13 (37%)
- Medical Device 4 (11%)
- Software 3 (9%)
- E-Commerce 3 (9%)
- Manufacturing 3 (9%)
Stage
- Seed 21 (60%)
- Pre-Seed 9 (26%)
- Series A 1 (3%)
- Venture - Series Unknown 1 (3%)
Country
- Poland 21 (60%)
- United Kingdom 2 (6%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CFO | Total investments: 0 | Find email | ||
Żaneta Kurszewska
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
Mikołaj Pióro
Investment Analyst
|
Investment Analyst | Total investments: 0 | Find email | |
Tomasz Chwiałkowski
Investment Director
|
Investment Director | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prosoma
|
Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | Series A / Jun 16, 2025 | |
MEDUCE
|
MEDUCE is a data management platform designed for healthcare businesses for conclusions based on historical data. | Seed / Jan 01, 2024 | |
Envirly
|
Envirly is a Polish technology company that offers an innovative platform for managing sustainable development, and the carbon footprint of organizations and products. | $1.5M / Seed / Nov 28, 2023 | |
Smarter Diagnostics
|
Smarter Diagnostics develops and uses AI-based medical device software for Magnetic Resonance image analysis in orthopedics and sports medicine. We provide radiology support software focusing on soft-tissue musculoskeletal disorders and applicable both in clinics and screening. With early detection of both local and systemic problems visible in MRIscans we deliver early detection of injury-causing pathologies and provide preventive measures to stop injuries. We also provide comprehensive MR-based and AI-driven diagnostic solutions for screening and health checks of active individuals across amateur and professional sports. | $702.2K / Pre-Seed / Oct 02, 2023 | |
|
Health Networks
|
Mobile App, SaaS, Wellbeing | $247.1K / Seed / Feb 28, 2023 | |
|
TJLE
|
HealthCare Hardware | $235.9K / Seed / Feb 28, 2023 | |
|
Envirly
|
Envirly is a Polish technology company that offers an innovative platform for managing sustainable development, and the carbon footprint of organizations and products. | $240.9K / Seed / Jan 19, 2023 | |
carein
|
Carein offers dermosuplemets targeting dermatological problems and improving the complexion. Its aim is to provide effective active ingredients to support skin regeneration from within, ensuring their better absorption, compared to external care. Product formulations developed by Carein scientists and experts address the most common skin problems,i.e. acne, broken capillaries, hyperpigmentation, or loss of skin firmness. Carein supports the #SKINPOSITIVITY movement, whose mission is to accept one's appearance. Carein helps to wisely nourish the skin from the inside but also uses the knowledge of psychodermatology to support and accept ourselves. | Seed / Jan 17, 2023 | |
Predictwatch
|
Predictwatch helps users overcome addictions like porn, gaming, and marijuana by tracking habits and supporting self control. | $253.7K / Venture - Series Unknown / Jan 15, 2023 | |
|
L-CONE
|
FSMP | $251K / Seed / Dec 30, 2022 | |
| See all 35 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Aligo Venture Capital invest in?
Aligo Venture Capital invests primarily in Health Care, Medical Device and Software startups, most often at Seed and Pre-Seed stage. Most of the 35 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Aligo Venture Capital's check size?
Aligo Venture Capital typically joins rounds of $241k–$682k at Seed and $250k–$702k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Aligo Venture Capital participates in.
How do I contact Aligo Venture Capital?
Public channels for Aligo Venture Capital include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aligo Venture Capital?
The team at Aligo Venture Capital includes Agnieszka Stochmal (CFO), Żaneta Kurszewska (Investment Manager) and Mikołaj Pióro (Investment Analyst). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
